Global Cystoscope Market By Type (Flexible Systoscope, and Rigid Cystoscope), By Application (Hospitals, Clinics, Ambulatory Surgical Centers), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2030 (Includes Business Impact of COVID-19)

                                          
Report updated on 11th September, 2021: Global Cystoscope Market By Type (Flexible Systoscope, and Rigid Cystoscope), By Application (Hospitals, Clinics, Ambulatory Surgical Centers), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2030 (Includes Business Impact of COVID-19)
Trusted Business Insights has published a comprehensive market research report on, Global Cystoscope Market by Product Type(Rigid Cystoscope, Flexible Cystoscope), By End-Use (Hospitals, Clinics, Ambulatory Surgical Centers), and by Region -Global Forecast to 2030. It offers a holistic view of the Global Cystoscope Market through systematic segmentation that covers every aspect of the target market.

The Global Cystoscope Market was valued at US$ 392.0 Mn in 2020 and is estimated to reach a value of US$ 691.2 Mn by 2030 at a CAGR of 5.8%.

A cystoscope is a medical device which comprises of a thin tube, camera and light which helps the surgeon to examine the lining of the infected bladder and whole length of the urethra. This process provides a better inspection as then; the doctor has magnified images of the bladder on display with the help of the camera. Cystoscopy can be done after applying the local anaesthetic jelly to soothe the urethra or with the help of a sedative drug. Flexible endoscopy technology reduces discomfort amongst patients during the operation, as surgeons operate them by using flexible instrumentation.

Urinary bladder cancer is the fifth most lethal cancer across the world. The rise in the number of cases of bladder cancer is expected to drive the market of cystoscope globally. Also, the advancement in technologies in the healthcare sector is expected to aid market growth.


Global Cystoscope Market Revenue (US$ Mn), 2021 to 2030


There are some drivers for the Global Cystoscope Market, which aid in the growth of the market such as - an ever-increasing geriatric population worldwide, increasing fascination towards minimally invasive surgery, rising prevalence of bladder cancer, advancement in cystoscope technology and improvement in the healthcare infrastructure of emerging nations, to name a few.

The shortage of skilled professionals who can perform the process is a major factor expected to hinder the growth of the Global Cystoscope Market. Contamination threats associated with cystoscopy and high prices of cystoscope are also some factors which could hamper the growth of the Global Cystoscope Market.

Advancement in HD technology and miniaturized systems, and a novel approach towards new technologies are some of the opportunities for the growth of Global Cystoscope Market. Global Cystoscope Market is segmented on the basis of product type, end-user and region.


Global Cystoscope Market by Product Type


On the basis of product type, the market is segmented into Rigid Cystoscope and Flexible Cystoscope. Flexible cystoscope accounts for the majority share in the Global Cystoscope Market and is projected to grow at a steady pace over the forecast period.

On the basis of end user, the market is segmented into Hospitals, Clinics and Ambulatory Surgical Centers. The hospitals segment is expected to grow at a CAGR of over 4% during the forecast period, registering a stable growth.

On the basis of region, the market is segmented into the United States, China, Europe, Japan, Southeast Asia, South America, South Africa, India and the rest of the world. The United States accounts for the majority share in the

Global Cystoscope Market, followed by Europe. The United States market is estimated to grow at a CAGR of over 4% during the forecast period.

Emerging economies such as China and India are expected to register the highest growth rate over the forecast period. India is estimated to grow at a CAGR of over 6% during the forecast period. Apart from the rest of the world, countries and regions such as Japan and Southeast Asia are expected to register stable growth over the forecast period.

The research report on the Global Cystoscope Market includes profiles of some of the major companies such as KARL STORZ GmbH & Co. KG, Olympus Corporation, Stryker Corporation, Richard Wolf GmbH, Zhejiang Tiansong Medical Instrument Co. Ltd., Shenyang Shenda Endoscope Co. Ltd., Ackermann Instrument, Boston Scientific Corporation, Becton, Dickinson and Company, HOYA Corporation, SCHA–LLY FIBEROPTIC GMBH, etc.


Below are the active patents related to Cystoscope Market.


Patent Number:- US20140121458A1

Lithotripsy Apparatus Using a Flexible Endoscope

Abstract

An apparatus is presented comprising an endoscope including a flexible shaft which has an active deflection section at a distal tip, a handle connected to a proximal end of the flexible shaft, a platform mounted to a top portion of the handle and oriented substantially in line with the longitudinal axis of the proximal end of a straight portion of the flexible shaft to provide a substantially straight entry into a working channel of the flexible shaft for an output accessory, a stone retrieval device insertable into the proximal end of the working channel of the endoscope, a lithotripsy shaft including one or more guide features at a distal end of the lithotripsy shaft to facilitate passage of wires or filaments of the stone retrieval device there through, and a lithotripsy shaft driver attached to the platform for driving the lithotripsy shaft under power.

Application File Date:- 2013-03-13

Application Granted Date:- 2015-10-27

Current Assignee:- Gyrus ACMI Inc

Patent Number:- US20150065807A1

4-way cystoscopy catheter

Abstract

Systems and methods of cannulating a body orifice such as a bladder are disclosed. A cystoscopy catheter can include a proximal end, a distal end having at least one exit port, and a flexible elongate tubular body therebetween; an inflatable balloon near the distal end of the catheter, the balloon transformable from an unexpanded and an expanded configuration; a first proximal port for fluid inflow; a second proximal port for fluid outflow; a third proximal port for balloon inflation, in fluid connection with the balloon; and a fourth proximal port for insertion of a diagnostic and/or therapeutic instrument such as a cystoscope therethrough, wherein the first, second, and fourth proximal ports are fluidly connected to a common central lumen extending through the elongate tubular body to the exit port on the distal end.

Application File Date:- 2014-11-14

Application Granted Date:- 2015-10-06

Current Assignee:- EMMY MEDICAL LLC

Patent Number:- DE102004043460B4

Ureteroscope with a shaft

Abstract

Ureteroscope with a shaft (1), which accommodates an optic (6), a light guide and an inflow channel (4), and with a return channel (10), characterized in that the return channel (10) is formed from outside the shaft (1). is formed over at least a portion of the length of the shaft in substantially longitudinally extending groove (8) that the shaft (1) is formed in a proximal portion of round cross-section and in a distal portion of oval cross-section, and that in a central portion of the shank (1) corresponds to the cross section in a first peripheral portion of the round cross section of the proximal portion of the shaft (1) and in a second peripheral portion of the oval cross section of the distal portion of the shank (1), wherein in the transition region between these two cross-sectional parts each have a groove (8) is formed.

Application File Date:- 2004-09-06

Application Granted Date:- 2016-04-07

Current Assignee:- Olympus Winter and Ibe GmbH

Key Market Segments

By Type

  
Flexible Systoscope
  
Rigid Cystoscope

BY Application

  
Hospitals
  
Clinics
  
Ambulatory Surgical Centers


Key Market Players included in the report:


  
Ackermann Instrument
  
Advanced Health Care Resources
  
Ambu A/S
  
BD
  
Becton
  
Boston Scientific Corporation
  
Coloplast
  
Dickinson Company
  
ELEPS
  
EndoMed Systems
  
FUJIFILM Corporation
  
Henke-Sass
  
HOYA Corporation
  
KARL STORZ GmbH & Co. KG
  
Laborie Inc.
  
Maxer Endoscopy GmbH
  
Medline Industries
  
OLYMPUS CORPORATION
  
PENTAX Medical and Stryker
  
Richard Wolf GmbH
  
SCHÖLLY FIBEROPTIC GMBH
  
Shenyang Shenda Endoscope Co. Ltd.
  
Stryker Corporation
  
Wolf GmbH
  
Zhejiang Tiansong Medical Instrument Co. Ltd.


Below are the key development related to Cystoscope Market in 2020 and 2021.


July 2021: The Association of Physicians of India (API) has launched therapy-specific teleconsultation recommendations, in collaboration with Abbott. This robust set of recommendations outlines best practices on adopting teleconsultation across various therapeutic areas, currently catering specifically to cardiology, diabetes, gastroenterology and adult immunization with plans to cover more specialties in the future. Source

July 2021: Fujifilm Invests $850M to Expand Biologics Capabilities. Fujifilm Corporation is making and $850 million investment to the grow its core Bio CDMO subsidiary, Fujifilm Diosynth Biotechnologies, a biologics contract development and manufacturing organization (CDMO) with over thirty years of experience in the development and manufacturing of recombinant proteins, vaccines, monoclonal antibodies, among other large molecules and viral products expressed in a wide array of microbial, mammalian, and host/virus systems. Source

July 2021: Fujifilm launches a more comprehensive portfolio for Europes healthcare community following the integration of Hitachi Diagnostic Imaging. at a virtual European event, the newly named FUJIFILM Healthcare Europe and FUJIFILM Europe’s existing European medical business (hereinafter referred to as “Fujifilm”) presented a complete and integrated portfolio of diagnostic products and services, including CT, MRI, X-ray, AI, PACS, endoscopy and ultrasound systems. The launch follows the completion of Fujifilms acquisition and takeover of Hitachis Diagnostic Imaging-related business on 31 March 2021 for 179 billion yen (€1.3 billion), with the newly named FUJIFILM Healthcare Europe also launching. Source

June 2021: BD Announces Expanded 510(k) Clearance for At-Home System for Ascites. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the PeritX™ Peritoneal Catheter System for the drainage of symptomatic, recurrent non-malignant ascites. Ascites is a debilitating condition that causes the build-up of fluid in the abdomen. Source